The drop was largely credited to a decline in lung cancer deaths due to advances in treatments, among other factors, the American Cancer Society said.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology